These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3671821)

  • 21. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of problem behaviour during medication evaluations.
    Zarcone J; Napolitano D; Valdovinos M
    J Intellect Disabil Res; 2008 Dec; 52(12):1015-28. PubMed ID: 18717764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health nurses' perception of their roles in relation to psychotropic drug use by adolescents: a phenomenographic study.
    Steffenak AK; Nordström G; Hartz I; Wilde-Larsson B
    J Clin Nurs; 2015 Apr; 24(7-8):970-9. PubMed ID: 25639291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
    de Kuijper G; van der Putten AAJ
    J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
    Hogg J
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitude to medication of parents/primary carers of people with intellectual disability.
    Rasaratnam R; Crouch K; Regan A
    J Intellect Disabil Res; 2004 Nov; 48(Pt 8):754-63. PubMed ID: 15494065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring drugs in hospitals for the mentally handicapped.
    James DH
    Br J Psychiatry; 1983 Feb; 142():163-5. PubMed ID: 6839070
    [No Abstract]   [Full Text] [Related]  

  • 28. Self-injurious behavior: a state-wide prevalence survey of the extent and circumstances.
    Griffin JC; Williams DE; Stark MT; Altmeyer BK; Mason M
    Appl Res Ment Retard; 1986; 7(1):105-16. PubMed ID: 3963804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior analysis of pharmacological and contingency management interventions for self-injury.
    Luiselli JK
    J Behav Ther Exp Psychiatry; 1986 Dec; 17(4):275-84. PubMed ID: 3805312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods of assessment of drug administration in a psychiatric hospital.
    Ballinger BR; Ramsay AC; Stewart MJ
    Br J Psychiatry; 1975 Nov; 127():494-8. PubMed ID: 1203641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment of self-injurious behavior in mentally retarded persons.
    Singh NN; Millichamp CJ
    J Autism Dev Disord; 1985 Sep; 15(3):257-67. PubMed ID: 2863252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sultopride therapy of behavior disorders in a child with severe mental retardation].
    Samouelian J
    Ann Pediatr (Paris); 1985 Mar; 32(3 Pt 2):321-2. PubMed ID: 4004042
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotropic drug use with successful and unsuccessful community placed developmentally disabled groups.
    Harder SR; Kalachnik JE; Jensen MA; Feltz J
    Res Dev Disabil; 1987; 8(2):191-202. PubMed ID: 2890188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.